Pharmacor Olmesartan Amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; silicified microcrystalline cellulose; stearic acid; pregelatinised maize starch; magnesium stearate; titanium dioxide; iron oxide yellow; purified talc; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AKM Olmesartan Amlodipine 20/10 olmesartan medoxomil 20 mg / amlodipine (as besilate) 10 mg tablets blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

akm olmesartan amlodipine 20/10 olmesartan medoxomil 20 mg / amlodipine (as besilate) 10 mg tablets blister pack

pharmacor pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; stearic acid; magnesium stearate; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Pharmacor Olmesartan Amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets blister pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; pregelatinised maize starch; stearic acid; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Pharmacor Olmesartan Amlodipine 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablets bottle pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan amlodipine 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablets bottle pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; stearic acid; pregelatinised maize starch; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Pharmacor Olmesartan Amlodipine 40/10 olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablets bottle pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan amlodipine 40/10 olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablets bottle pack

pharmacor pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; stearic acid; pregelatinised maize starch; croscarmellose sodium; silicified microcrystalline cellulose; titanium dioxide; iron oxide yellow; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AKM Olmesartan Amlodipine 40/10 olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablets blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

akm olmesartan amlodipine 40/10 olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablets blister pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: stearic acid; pregelatinised maize starch; silicified microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AKM Olmesartan Amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

akm olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; stearic acid; silicified microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Pharmacor Olmesartan Amlodipine 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablets blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan amlodipine 20/5 olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablets blister pack

pharmacor pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: stearic acid; pregelatinised maize starch; magnesium stearate; croscarmellose sodium; silicified microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

BRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

brineura cerliponase alfa (rch) 150 mg/5 ml solution for injection vial with flushing solution vial

biomarin pharmaceutical australia pty ltd - cerliponase alfa, quantity: 30 mg/ml - injection, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium chloride; potassium chloride; magnesium chloride hexahydrate; calcium chloride dihydrate; water for injections; monobasic sodium phosphate monohydrate - brineura is indicated for the treatment of neuronal ceroid lipofuscinosis type 2 (cln2) disease, also known as tripeptidyl peptidase 1 (tpp1) deficiency.

OLMESARTAN/ AMLODIPINE Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.888 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - olmesartan/ amlodipine-myl is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.